- 5-ASA
- Brand names
- Both Metabolised by bacteria to sulfapyridine and 5-ASA
- Decreases synthesis of prostaglandin and leukotriene, modulating the inflammatory response derived from the cyclooxygenase and lipooxygenase pathways.
- These preparations are more useful in UC than Crohns – can be given orally or rectally.
- First line in mild/moderate UC.